MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Gesamtverbindlichkeiten 2011-2026 | QTNT
Gesamtverbindlichkeiten Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 255 M | 232 M | 176 M | 138 M | 134 M | 73 M | 82.7 M | 61.3 M | 36 M | 31 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 255 M | 31 M | 122 M |
Gesamtverbindlichkeiten Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 328 M | 310 M | 326 M | 338 M | 334 M | 335 M | 338 M | 328 M | 244 M | 238 M | 238 M | 231 M | 230 M | 224 M | 215 M | 176 M | 166 M | 169 M | 167 M | 138 M | 134 M | 139 M | 134 M | 134 M | 129 M | 74.4 M | 74.2 M | 73 M | 63.4 M | 74.8 M | 81.9 M | 81.8 M | 74.5 M | 38.5 M | 35.1 M | 30.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 338 M | 30.6 M | 179 M |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
5.32 B | $ 115.35 | -2.33 % | $ 35.1 B |  USA |
 |
Anixa Biosciences
ANIX
|
2.13 M | $ 2.81 | -2.7 % | $ 91.2 K | USA |
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
14.4 M | $ 12.28 | -2.69 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | Israel |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 22.48 | -1.58 % | $ 234 M |  China |
 |
Bioventus
BVS
|
455 M | $ 8.45 | -7.14 % | $ 563 M | USA |
 |
Celcuity
CELC
|
130 M | $ 114.85 | -0.34 % | $ 4.53 B | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 27.23 | -2.44 % | $ 756 M | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 175.23 | -3.37 % | $ 8.69 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Co-Diagnostics
CODX
|
9.31 M | - | - | $ 79.8 M | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 14.59 | 2.41 % | $ 441 M | USA |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
76.4 M | $ 18.61 | 17.37 % | $ 2.41 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 124.76 | -2.71 % | $ 19.8 B | USA |
 |
IQVIA Holdings
IQV
|
23.3 B | $ 175.33 | -1.8 % | $ 30.1 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.11 | -1.36 % | $ 1.41 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 199.8 | -2.07 % | $ 22.2 B | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 195.75 | -2.99 % | $ 140 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.75 B | $ 607.19 | -1.9 % | $ 48.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | $ 103.5 | 0.17 % | $ 19.5 B | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 9.69 | -3.0 % | $ 275 M | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 269.52 | -2.34 % | $ 22.4 B | USA |
 |
DexCom
DXCM
|
3.59 B | $ 68.5 | -3.1 % | $ 26.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 107.08 | -3.19 % | $ 8.83 B |  Irlanda |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 72.86 | -4.53 % | $ 4.92 B | USA |
 |
CareDx, Inc
CDNA
|
110 M | $ 17.91 | -4.48 % | $ 954 M | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 215.85 | -3.66 % | $ 25.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
339 M | $ 5.15 | 0.29 % | $ 477 M | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.92 | -2.3 % | $ 1.14 B | USA |
 |
National Research Corporation
NRC
|
121 M | $ 14.48 | 3.13 % | $ 324 M | USA |
 |
Guardant Health
GH
|
2.11 B | $ 91.56 | -1.1 % | $ 11.5 B | USA |
 |
Natera
NTRA
|
689 M | $ 196.94 | -0.1 % | $ 19.4 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
OPKO Health
OPK
|
835 M | $ 1.18 | 0.43 % | $ 819 M | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |